friedelin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alharbi, SA; Alrashood, ST; Duraipandiyan, V; Ignacimuthu, S; Irudayaraj, SS; Sunil, C | 1 |
| Adongo, DW; Amponsah, IK; Baah, MK; Ben, IO; Fleischer, TC; Harley, BK; Mensah, AY; Mireku-Gyimah, NA | 1 |
2 other study(ies) available for friedelin and Alloxan Diabetes
| Article | Year |
|---|---|
Friedelin exhibits antidiabetic effect in diabetic rats via modulation of glucose metabolism in liver and muscle.
Topics: Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glucose; Hypoglycemic Agents; Liver; Male; Muscle, Skeletal; Rats; Rats, Wistar; Triterpenes | 2021 |
Myrianthus libericus: Possible mechanisms of hypoglycaemic action and in silico prediction of pharmacokinetics and toxicity profile of its bioactive metabolite, friedelan-3-one.
Topics: alpha-Amylases; Animals; Cell Line; Computer Simulation; Diabetes Mellitus, Experimental; Glucose; Glucose Transporter Type 4; Glyburide; Hypoglycemic Agents; Lipid Metabolism; Male; Muscle Fibers, Skeletal; Phosphatidylinositol 3-Kinases; Plant Bark; PPAR gamma; Rats; Rats, Sprague-Dawley; Triterpenes; Up-Regulation; Urticaceae | 2021 |